Valuation: Innovassynth Technologies (India) Limited

Market Cap 5.22B 54.66M 47.52M 44.23M 40.61M 76.68M 77.87M 521M 205M 2.6B 205M 201M 8.71B P/E 2024
-73.1x
P/E 2025 -44.1x
Enterprise Value 5.26B 55.12M 47.91M 44.6M 40.95M 77.32M 78.52M 526M 206M 2.62B 207M 202M 8.78B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
20.16%
Yield 2024 *
-
Yield 2025 -
1 day+0.97%
1 week+0.97%
Current month+0.97%
1 month+3.98%
3 months+108.84%
6 months+96.77%
Current year+68.80%
1 month 130.65
Extreme 130.65
135.85
Current year 50.1
Extreme 50.1
135.85
1 year 50.1
Extreme 50.1
139.85
3 years 19.5
Extreme 19.5
139.85
5 years 11.78
Extreme 11.78
139.85
10 years 2.43
Extreme 2.43
139.85
Manager TitleAgeSince
Chief Executive Officer 51 2022-02-11
Director of Finance/CFO 52 2025-12-22
Chief Operating Officer - 2025-12-22
Director TitleAgeSince
Chairman 51 2022-02-11
Director/Board Member - 2022-09-01
Director/Board Member 58 2024-04-15
Change 5-day change 1-year change 3-year change Capi.($)
+0.97%+0.97%+6.84%+517.50% 131M
-0.61%+3.30%+6.37%+50.14% 78.14B
+0.19%+0.25%-5.84%+13.15% 36.85B
+1.64%+14.39%-2.92%-31.23% 36.06B
+0.16%-1.38%+22.15%+41.55% 28.07B
+1.41%+5.08%+29.20%+17.04% 23.63B
-2.00%-2.43%+87.32%-4.89% 19.15B
-1.33%-0.51%-34.71%-40.21% 18.5B
-0.30%+1.86%+9.53%-4.17% 14.02B
-0.10%+2.43%+73.25%-42.02% 13.87B
Average +0.02%+3.17%+19.12%+51.69% 26.84B
Weighted average by Cap. -0.06%+4.14%+13.67%+12.80%

Financials

2024 2025
Net sales - -
Net income -8.44M -88.42K -76.87K -71.55K -65.69K -124K -126K -843K -331K -4.2M -332K -325K -14.09M -46.87M -491K -427K -397K -365K -689K -700K -4.68M -1.84M -23.34M -1.84M -1.8M -78.25M
Net Debt 35.78M 375K 326K 303K 278K 526K 534K 3.58M 1.4M 17.81M 1.41M 1.38M 59.73M 43.45M 455K 396K 368K 338K 638K 648K 4.34M 1.7M 21.63M 1.71M 1.67M 72.53M
Logo Innovassynth Technologies (India) Limited
Innovassynth Technologies (India) Limited, formerly Innovassynth Investments Limited, is an India-based company, which is engaged in developing, scaling up and manufacturing of specialty chemicals and pharmaceuticals intermediates. The Company is engaged in custom development and manufacturing. It partners with pharma and diagnostics, organometallics, petrochemical and polymers, flavors and fragrance, and specialty chemical companies worldwide. Through its two business verticals, the Company offers solutions and a range organic chemical portfolio: life sciences - nucleosides and specialty chemicals. Its Life Sciences - Nucleosides vertical includes Nucleosides - Phosphoramidite, Delivery Platforms (GalNAc), Pharma Intermediates, Nucleosides - Reagents & Bio-buffers, and ADC Linkers. Its specialty chemicals include organometallics including pre-catalysts for metallocene, ZN catalysts and donors, polymers additives, ALD/CVD precursors, donors & ligands, and semiconductor chemicals.
Employees
2
Date Price Change Volume
26-08-03 135.85 +0.97% 24,005
  1. Stock Market
  2. Stocks
  3. INOVSYNTH6 Stock